🇺🇸 FDA
Pipeline program

BAX69 + infusional 5-FU/LV

391401

Phase 2 mab terminated

Quick answer

BAX69 + infusional 5-FU/LV for Metastatic Colorectal Cancer is a Phase 2 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Metastatic Colorectal Cancer
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials